Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of T Cell Surface Glycoprotein CD3 Epsilon Chain market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of T Cell Surface Glycoprotein CD3 Epsilon Chainmarket, defines the market attractiveness level of T Cell Surface Glycoprotein CD3 Epsilon Chain market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of T Cell Surface Glycoprotein CD3 Epsilon Chain industry, describes the types of T Cell Surface Glycoprotein CD3 Epsilon Chain market, the applications of major players and the market size, and deeply analyzes the current situation of the global T Cell Surface Glycoprotein CD3 Epsilon Chain market and the development prospects and opportunities of T Cell Surface Glycoprotein CD3 Epsilon Chain industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global T Cell Surface Glycoprotein CD3 Epsilon Chain market in Chapter 13.
By Player:
Meridigen Biotech Co Ltd
F Hoffmann-La Roche Ltd
SYNIMMUNE GmbH
GlaxoSmithKline Plc
Celgene Corp
Amgen Inc
Numab Innovation AG
MacroGenics Inc
Tiziana Life Sciences Plc
By Type:
ND-007
Foralumab
Coltelizumab
AVA-002
Others
By End-User:
Autoimmune Disorders
Hepatitis B
Multiple Sclerosis
Prostate Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 T Cell Surface Glycoprotein CD3 Epsilon Chain Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 T Cell Surface Glycoprotein CD3 Epsilon Chain Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise T Cell Surface Glycoprotein CD3 Epsilon Chain Market Analysis and Outlook to 2022
-
7.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2017-2022)
-
7.2 United States T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2017-2022)
-
7.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2017-2022)
-
7.4 China T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2017-2022)
-
7.5 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2017-2022)
-
7.6 India T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2017-2022)
-
7.7 South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2017-2022)
8 Region and Country-wise T Cell Surface Glycoprotein CD3 Epsilon Chain Market Analysis and Outlook to 2028
-
8.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2022-2028)
-
8.2 United States T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2022-2028)
-
8.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2022-2028)
-
8.4 China T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2022-2028)
-
8.5 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2022-2028)
-
8.6 India T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2022-2028)
-
8.7 South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2022-2028)
9 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Outlook by Types and Applications to 2022
-
9.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ND-007 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Foralumab Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Coltelizumab Consumption and Growth Rate (2017-2022)
-
9.1.4 Global AVA-002 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Outlook by Types and Applications to 2028
-
10.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ND-007 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Foralumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Coltelizumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global AVA-002 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Import and Export Analysis (Top 5 Countries)
-
11.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Competitive Analysis
-
14.1 Meridigen Biotech Co Ltd
-
14.1.1 Meridigen Biotech Co Ltd Company Details
-
14.1.2 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
14.2 F Hoffmann-La Roche Ltd
-
14.2.1 F Hoffmann-La Roche Ltd Company Details
-
14.2.2 F Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 F Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
14.3 SYNIMMUNE GmbH
-
14.3.1 SYNIMMUNE GmbH Company Details
-
14.3.2 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
14.4 GlaxoSmithKline Plc
-
14.4.1 GlaxoSmithKline Plc Company Details
-
14.4.2 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
14.5 Celgene Corp
-
14.5.1 Celgene Corp Company Details
-
14.5.2 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
14.6 Amgen Inc
-
14.6.1 Amgen Inc Company Details
-
14.6.2 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
14.7 Numab Innovation AG
-
14.7.1 Numab Innovation AG Company Details
-
14.7.2 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
14.8 MacroGenics Inc
-
14.8.1 MacroGenics Inc Company Details
-
14.8.2 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
14.9 Tiziana Life Sciences Plc
-
14.9.1 Tiziana Life Sciences Plc Company Details
-
14.9.2 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of T Cell Surface Glycoprotein CD3 Epsilon Chain
-
Figure T Cell Surface Glycoprotein CD3 Epsilon Chain Picture
-
Table Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption by Country (2017-2022)
-
Figure United States T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption and Growth Rate (2017-2022)
-
Table Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption and Growth Rate (2017-2022)
-
Figure China T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption and Growth Rate (2017-2022)
-
Figure Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption and Growth Rate (2017-2022)
-
Figure India T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption and Growth Rate (2017-2022)
-
Figure South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption and Growth Rate (2017-2022)
-
Figure Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast by Country (2022-2028)
-
Figure United States T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast and Growth Rate (2022-2028)
-
Figure China T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast and Growth Rate (2022-2028)
-
Figure India T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ND-007 Consumption and Growth Rate (2017-2022)
-
Figure Global Foralumab Consumption and Growth Rate (2017-2022)
-
Figure Global Coltelizumab Consumption and Growth Rate (2017-2022)
-
Figure Global AVA-002 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global ND-007 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Foralumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Coltelizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AVA-002 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global T Cell Surface Glycoprotein CD3 Epsilon Chain Import by Region (Top 5 Countries) (2017-2028)
-
Table Global T Cell Surface Glycoprotein CD3 Epsilon Chain Export by Region (Top 5 Countries) (2017-2028)
-
Table Meridigen Biotech Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
Table SYNIMMUNE GmbH (Foundation Year, Company Profile and etc.)
-
Table SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
Table SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
Table Celgene Corp (Foundation Year, Company Profile and etc.)
-
Table Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
Table Numab Innovation AG (Foundation Year, Company Profile and etc.)
-
Table Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
Table MacroGenics Inc (Foundation Year, Company Profile and etc.)
-
Table MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
Table MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
Table Tiziana Life Sciences Plc (Foundation Year, Company Profile and etc.)
-
Table Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Service
-
